Share

October 2017; 7 (5) Case

Total spinal and brainstem anesthesia as complication of paravertebral ropivacaine administration

Laura A. Foster, Cole K. Deutz, Jacob L. Hutchins, Jeffrey A. Allen
First published April 25, 2017, DOI: https://doi.org/10.1212/CPJ.0000000000000355
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
57

Share

Article Information

vol. 7 no. 5 430-432
DOI: 
https://doi.org/10.1212/CPJ.0000000000000355
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 15, 2016
  • Accepted February 21, 2017
  • First Published April 25, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Laura A. Foster, MD,
    2. Cole K. Deutz, MD,
    3. Jacob L. Hutchins, MD and
    4. Jeffrey A. Allen, MD
  1. Laura A. Foster, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Cole K. Deutz, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jacob L. Hutchins, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker's bureau for Pacira Pharmaceuticals

    Editorial Boards:

    1. Practical Reviews in Anesthesiology Oakstone Medical Publishing.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. consultant for Heron Therapeutics, Pacira Pharmaceuticals, Worrell, AtriCure, Insitu Biologics, and GLG

    Speakers' Bureaus:

    1. Pacira Pharmaceuticals, Halyard Health

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. I am an anesthesiologist and provide regional anesthesia to patients with elastomeric pumps used in this case report.

    Research Support, Commercial Entities:

    1. Pacira Pharmaceuticals Acel Rx

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Insitu Biologics

    Stock/Stock Options, Medical Equipment & Materials:

    1. SpineThera

    Legal Proceedings:

    1. NONE

  4. Jeffrey A. Allen, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Grifols, speaker honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Axcelacare (2) CSL Behring (3) Grifols

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Departments of Neurology (LAF), Brigham and Women's Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston; and Departments of Anesthesiology (CKD, JLH) and Neurology (JAA), University of Minnesota, Minneapolis.
  1. Correspondence to:
    lfoster7{at}partners.org
View Full Text

Article usage

Article usage: April 2017 to September 2022

AbstractFullPdfSource
Apr 20176904Highwire
May 201713803Highwire
Jun 20175304Highwire
Jul 20173403Highwire
Aug 20173100Highwire
Sep 20174800Highwire
Oct 201733897Highwire
Nov 201743726Highwire
Dec 201712317Highwire
Jan 20186223Highwire
Feb 20184610Highwire
Mar 20184720Highwire
Apr 20187210Highwire
May 20189112Highwire
Jun 20185933Highwire
Jul 20184300Highwire
Aug 20185810Highwire
Sep 201816821Highwire
Oct 201824000Highwire
Nov 201820610Highwire
Dec 201820410Highwire
Jan 20199330Highwire
Feb 20195411Highwire
Mar 20193210Highwire
Apr 20192610Highwire
May 20191600Highwire
Jun 20192611Highwire
Jul 20194800Highwire
Aug 20191210Highwire
Sep 20191400Highwire
Oct 20191703Highwire
Nov 20192700Highwire
Dec 20192100Highwire
Jan 20201510Highwire
Feb 20201300Highwire
Mar 20201100Highwire
Apr 20201400Highwire
May 20201700Highwire
Jun 20201310Highwire
Jul 2020600Highwire
Aug 2020601Highwire
Sep 20201410Highwire
Oct 20202600Highwire
Nov 20203012Highwire
Dec 20202011Highwire
Jan 20212201Highwire
Feb 20212400Highwire
Mar 20212500Highwire
Apr 20211600Highwire
May 20213400Highwire
Jun 20211500Highwire
Jul 20213010Highwire
Aug 20212400Highwire
Sep 20212700Highwire
Oct 20211900Highwire
Nov 20212300Highwire
Dec 20211100Highwire
Jan 20223100Highwire
Feb 20223400Highwire
Mar 20223500Highwire
Apr 20222901Highwire
May 20224431Highwire
Jun 20221000Highwire
Jul 20221401Highwire
Aug 20223100Highwire
Sep 20223811Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me